Shruti K Gohil1, Raveena Singh2, Justin Chang2, Adrijana Gombosev2, Tom Tjoa2, Matthew Zahn3, Patti Steger4, Susan S Huang2. 1. Division of Infectious Diseases and Health Policy Research Institute, University of California Irvine School of Medicine, Irvine, CA. Electronic address: skgohil@uci.edu. 2. Division of Infectious Diseases and Health Policy Research Institute, University of California Irvine School of Medicine, Irvine, CA. 3. Orange County Health Care Agency, Santa Ana, CA. 4. Association for Professionals in Infection Control and Epidemiology, Chapter 029 Orange County, Orange, CA.
Abstract
BACKGROUND: The east-to-west spread of carbapenem-resistant Enterobacteriaceae (CRE) represents an opportunity to explore strategies to limit spread in nonendemic areas. We evaluated CRE emergence and regional support for containment strategies. METHODS: A 17-question cross-sectional survey was administered to infection prevention programs in Orange County, CA (31 hospitals serving 3 million residents), between January and September 2014. Questions addressed newly detected hospital- and community-onset CRE cultures (2008-2013), current CRE control strategies, and support for prevention strategies for a hypothetical regional intervention. RESULTS: Among 31 hospitals, 21 (68%, representing 17 infection prevention programs) completed the survey. CRE was scarcely detected between 2009-2010; within 4 years, 90% of hospitals reported CRE, with 2.5-fold higher community-onset than hospital-onset CRE. Between 2011 and 2013, annual CRE incidence increased 4.7-fold (1.4-6.3 cases/10,000 admissions). Support for a regional CRE prevention bundle was unanimous. Although 22% bathed patients positive for CRE with chlorhexidine gluconate and 11% actively screened for CRE, 86% and 57%, respectively, would consider these strategies in a regional intervention. CONCLUSIONS: CRE epidemiology in Orange County parallels early progression previously seen in now-endemic areas, representing an opportunity to consider interventions to prevent endemic spread. Many facilities would consider proactive strategies, such as chlorhexidine bathing, in the setting of a regional collaborative.
BACKGROUND: The east-to-west spread of carbapenem-resistant Enterobacteriaceae (CRE) represents an opportunity to explore strategies to limit spread in nonendemic areas. We evaluated CRE emergence and regional support for containment strategies. METHODS: A 17-question cross-sectional survey was administered to infection prevention programs in Orange County, CA (31 hospitals serving 3 million residents), between January and September 2014. Questions addressed newly detected hospital- and community-onset CRE cultures (2008-2013), current CRE control strategies, and support for prevention strategies for a hypothetical regional intervention. RESULTS: Among 31 hospitals, 21 (68%, representing 17 infection prevention programs) completed the survey. CRE was scarcely detected between 2009-2010; within 4 years, 90% of hospitals reported CRE, with 2.5-fold higher community-onset than hospital-onset CRE. Between 2011 and 2013, annual CRE incidence increased 4.7-fold (1.4-6.3 cases/10,000 admissions). Support for a regional CRE prevention bundle was unanimous. Although 22% bathed patients positive for CRE with chlorhexidine gluconate and 11% actively screened for CRE, 86% and 57%, respectively, would consider these strategies in a regional intervention. CONCLUSIONS: CRE epidemiology in Orange County parallels early progression previously seen in now-endemic areas, representing an opportunity to consider interventions to prevent endemic spread. Many facilities would consider proactive strategies, such as chlorhexidine bathing, in the setting of a regional collaborative.
Authors: John C O'Horo; Germana L M Silva; L Silvia Munoz-Price; Nasia Safdar Journal: Infect Control Hosp Epidemiol Date: 2012-01-25 Impact factor: 3.254
Authors: Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee Journal: Infect Control Hosp Epidemiol Date: 2010-11 Impact factor: 3.254
Authors: Sandeep Kochar; Timothy Sheard; Roopali Sharma; Alan Hui; Elaine Tolentino; George Allen; David Landman; Simona Bratu; Michael Augenbraun; John Quale Journal: Infect Control Hosp Epidemiol Date: 2009-05 Impact factor: 3.254
Authors: Matthew E Falagas; Giannoula S Tansarli; Drosos E Karageorgopoulos; Konstantinos Z Vardakas Journal: Emerg Infect Dis Date: 2014-07 Impact factor: 6.883
Authors: James A McKinnell; Raveena D Singh; Loren G Miller; Ken Kleinman; Gabrielle Gussin; Jiayi He; Raheeb Saavedra; Tabitha D Dutciuc; Marlene Estevez; Justin Chang; Lauren Heim; Stacey Yamaguchi; Harold Custodio; Shruti K Gohil; Steven Park; Steven Tam; Philip A Robinson; Thomas Tjoa; Jenny Nguyen; Kaye D Evans; Cassiana E Bittencourt; Bruce Y Lee; Leslie E Mueller; Sarah M Bartsch; John A Jernigan; Rachel B Slayton; Nimalie D Stone; Matthew Zahn; Vincent Mor; Kevin McConeghy; Rosa R Baier; Lynn Janssen; Kathleen O'Donnell; Robert A Weinstein; Mary K Hayden; Micaela H Coady; Megha Bhattarai; Ellena M Peterson; Susan S Huang Journal: Clin Infect Dis Date: 2019-10-15 Impact factor: 9.079
Authors: Gary Lin; Katie K Tseng; Oliver Gatalo; Diego A Martinez; Jeremiah S Hinson; Aaron M Milstone; Scott Levin; Eili Klein Journal: Infect Control Hosp Epidemiol Date: 2021-10-22 Impact factor: 6.520
Authors: Daniel J Livorsi; Margaret L Chorazy; Marin L Schweizer; Erin C Balkenende; Amy E Blevins; Rajeshwari Nair; Matthew H Samore; Richard E Nelson; Karim Khader; Eli N Perencevich Journal: Antimicrob Resist Infect Control Date: 2018-04-24 Impact factor: 4.887